| Literature DB >> 31364346 |
Gökmen Akkaya1, Çağatay Bilen1, Osman Nuri Tuncer1, Mehmet Fatih Ayık1, Yüksel Atay1.
Abstract
OBJECTIVE: This study aimed to evaluate the early operative outcomes and to compare the left ventricle and mitral valve functions after initial Takeuchi repair in patients with anomalous left coronary arising from pulmonary artery (ALCAPA).Entities:
Keywords: Bland White Garland Syndrome; Medical Records; Mitral Valve; Mitral Valve Insufficiency; Pulmonary Artery; Stroke Volume; Vascular Surgical Procedures
Mesh:
Year: 2019 PMID: 31364346 PMCID: PMC6894018 DOI: 10.21470/1678-9741-2018-0376
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Preoperative characteristics of patients.
| Age/sex | Weight (kg) | Major symptoms at presentation | LVEF | Preoperative MR | Inotropic support | Need of intubation | Concomitant anomaly | |
|---|---|---|---|---|---|---|---|---|
| 1 | 4m/F | 4 | Poor feeding | 35 | ‘1-2 | - | - | ASD |
| 2 | 2m/F | 4.5 | Dyspnea, sweating | 25 | ‘2 | - | - | ASD |
| 3 | 1y/M | 8.5 | Rapid breathing | 60 | ‘1 | - | - | - |
| 4 | 6m/M | 5 | Failure to thrive | 30 | ‘3 | + | - | - |
| 5 | 7m/F | 9 | Dyspnea, sweating | 25 | ‘2 | + | + | - |
| 6 | 6m/F | 6.5 | Tachypnea, sweating | 30 | ‘3-4 | + | + | - |
| 7 | 10y/F | 28 | Palpitation | 20 | ‘3 | + | + | - |
| 8 | 8y/M | 22 | Incidental murmur | 50 | ‘2 | - | - | LAD-RV fistula |
| 9 | 5m/M | 4 | Failure to thrive, dyspnea | 40 | ‘3 | - | - | - |
| 10 | 1y/F | 8 | Failure to thrive | 45 | ‘3-4 | - | - | - |
| 11 | 4m/F | 6 | Dyspnea, sweating | 40 | ‘1-2 | - | - | - |
| 12 | 1m/F | 3.5 | Dyspnea, poor feeding | 20 | ‘2 | + | - | - |
| 13 | 34y/F | 54 | Angina, palpitation | 60 | ‘1 | - | - | - |
| 14 | 25d/F | 4 | Dyspnea, sweating | 40 | ‘2 | - | - | ASD/PDA |
ASD=atrial septal defect; LVEF=left ventricle ejection fraction; MR=mitral regurgitation; PDA=patent ductus arteriosus
Operative results and postoperative outcomes.
| Characteristics | Valid (n=13) |
|---|---|
| CPB time, minutes | 100.7±23.86 |
| Aortic cross-clamp time, minutes | 85.18±19.36 |
| Mechanical ventilation, days | 2.5 (1-14) |
| ICU length of stay, days | 3.6 (1-14) |
| Hospital length of stay, days | 9.5 (5-14) |
| Hospital survival | 13 (92.8%) |
| Follow-up time, years | 4.3±3.05 |
| Mitral valve intervention | 0 |
| Coronary artery bypass | 1 |
| Septal defect closure | 3 |
| PDA closure | 1 |
| Left ventricular ejection fraction | 57± 6 |
| Residual mitral regurgitation | 5 |
| Trivial | 3 |
| Mild | 2 |
| Moderate | 0 |
| Severe | 0 |
Values are mean, SD or n (%). CPB=cardiopulmonary bypass; ICU=intensive care unit; PDA=patent ductus arteriosus
Fig. 1Left ventricle ejection fraction values.
Fig. 2Degrees of mitral regurgitation measurements.
| Abbreviations, acronyms & symbols | |
|---|---|
| ALCAPA | = Anomalous left coronary arising from pulmonary artery |
| ASD | = Atrial septal defect |
| CPB | = Cardiopulmonary bypass |
| ECMO | = Extracorporeal membrane oxygenation |
| LAD | = Left anterior descending |
| LVEF | = Left ventricular ejection fraction |
| MR | = Mitral regurgitation |
| MRG | = Myocardial revascularization group |
| NYHA | = New York Heart Association |
| PDA | = Patent ductus arteriosus |
| SD | = Standard deviation |
| TTE | = Transthoracic echocardiography |
| Authors’ roles & responsibilities | |
|---|---|
| GA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| ÇB | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| ONT | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| MFA | Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| YA | |